Ashland stock analysis
Ashland (AHT) Stock Price & Analysis
AHT Stock Chart & Stats
- Day’s Range
- EUR 68.00 - EUR 69.50
- 52-Week Range
- EUR 41.40 - EUR 69.50
- Previous Close
- EUR 68.50
- Volume
- N/A
- Average Volume (3M)
- 43
- Market Cap
- EUR 3.13B
- Enterprise Value
- EUR 4.12B
- Total Cash (Recent Filing)
- EUR 480.00M
- Total Debt (Recent Filing)
- EUR 1.47B
- Price to Earnings (P/E)
- 849.7
- Beta
- 0.60
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- 0.34
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.01%
Bulls Say, Bears Say
Bulls Say
Cash Generation
Strong operating and free cash flow provide internal funding for investment, debt service, and shareholder returns. The recovery from negative fiscal 2025 free cash flow, combined with substantial liquidity, improves Ashland’s ability to execute initiatives through normal business volatility.
Life Sciences And Personal Care
Life Sciences and Personal Care combine durable customer applications with strong volume growth and expanding margins. Pharma’s sixth consecutive quarter of volume growth and Personal Care’s innovation-led adoption support a more resilient, higher-quality earnings mix over coming quarters.
Innovation And Customer Adoption
A broad patent and product-launch pipeline can deepen differentiation across Ashland’s specialty platforms and support future mix improvement. The multi-year energy-storage win also adds potential volume stability as customer production ramps over the next 6–12 months.
Bears Say
Thin Net Profitability
Very thin net profitability leaves limited protection against operating setbacks, cost inflation, or weaker demand. The sharp contrast with fiscal 2025 losses also indicates that earnings power remains volatile, making sustained improvement dependent on consistent execution and margin recovery.
Hopewell Productivity Pressure
The Hopewell productivity gap is a direct drag on Specialty Additives profitability and is expected to affect the next quarter. Until output and asset utilization improve, under-absorption can suppress margins and offset gains from pricing, commercial momentum, and stronger customer volumes.
Lower Cash Conversion And Higher Capex
Lower expected cash conversion and higher planned capital spending could reduce near-term financial flexibility even if adjusted EBITDA grows. Inventory investment and debottlenecking projects may be strategically useful, but they raise the cash required to support operations and expansion.
AHT FAQ
What was Ashland’s price range in the past 12 months?
What is Ashland’s market cap?
When is Ashland’s upcoming earnings report date?
How were Ashland’s earnings last quarter?
Is Ashland overvalued?
Does Ashland pay dividends?
What is Ashland’s EPS estimate?
How many shares outstanding does Ashland have?
What happened to Ashland’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Ashland?
What is the TipRanks Smart Score and how is it calculated?
Ashland Stock Smart Score
Company Description
Ashland
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Guillermo Novo
- Employees
- 2,800
- Website
- www.ashland.com
- Address
- 8145 Blazer Drive, Wilmington, DE, 19808, US
Ashland (AHT) Earnings & Revenues
AHT Company Deck
AHT Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Ashland reported broad-based sales and volume growth, strong performance in Life Sciences and Personal Care, improving Intermediates profitability, substantial cash generation, strategic initiative outperformance, and a constructive fiscal 2027 outlook. These strengths were partially offset by Specialty Additives profitability pressure from Hopewell, soft construction and energy and resources markets, foreign-currency headwinds, higher planned capital expenditures, and lower expected free cash flow conversion.
View all DE:AHT earnings summariesAHT Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 3 | 4 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 12 | 0 | 0 |
